SOPHIA GENETICS SA (SOPH:NASDAQ)
$5.59 -0.06 (-1.0619%)
Analysed SOPHIA GENETICS SA (SOPH:NASDAQ) News Sources
Undervalued Opportunities: Top Penny Stocks To Watch In May 2026
21-05-2026
yahoo.com
SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center
04-06-2026
yahoo.com
Insider Spends US$99k Buying More Shares In SOPHiA GENETICS
07-06-2026
yahoo.com
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting
10-06-2026
yahoo.com
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares
16-06-2026
yahoo.com
SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares
17-06-2026
yahoo.com
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares
19-06-2026
yahoo.com
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting
22-06-2026
yahoo.com
Is SOPHiA GENETICS SA (SOPH) Among the Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On?
23-06-2026
yahoo.com
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026
21-07-2026
yahoo.com
What is the current price of SOPHIA GENETICS SA (SOPH:NASDAQ)?
The current price of SOPHIA GENETICS SA (SOPH:NASDAQ) is $5.59.
SOPHIA GENETICS SA (SOPH:NASDAQ) absolute price change since previous trading day?
The absolute price change of SOPHIA GENETICS SA (SOPH:NASDAQ) since the previous trading day is $-0.06.
SOPHIA GENETICS SA (SOPH:NASDAQ) percentage price change since previous trading day?
The percentage price change of SOPHIA GENETICS SA (SOPH:NASDAQ) since the previous trading day is -1.0619%.
What is the most recent average sentiment score for SOPHIA GENETICS SA (SOPH:NASDAQ)?
The most recent average sentiment score for SOPHIA GENETICS SA (SOPH:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for SOPHIA GENETICS SA (SOPH:NASDAQ)?
The most recent sentiment for SOPHIA GENETICS SA (SOPH:NASDAQ) is .
SEC-8K** Filing Available For SOPHIA GENETICS SA (SOPH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.